Scipher Medicine
OverviewSuggest Edit
Scipher Medicine is a company developing medical diagnostics solutions. It offers a platform for identification which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias.
| Type | Private | |
| Founded | 2014 | |
| HQ | Waltham, MA, US | Map |
| Website | sciphermedicine.com |
Recent NewsAll News
- New Study Demonstrates Clinical Utility of PrismRA Test in Guiding Therapy Selection for Rheumatoid Arthritis Patients
- 18th U.S. Surgeon General Joins Scipher Medicine
- Scipher Medicine and Ambry Genetics Partner to Bring Precision Medicine Test for Rheumatoid Arthritis to Market
- New Strategy for Avoiding Waste and Improving Response for Highest Cost Therapies in Rheumatoid Arthritis
Latest Updates
| Employees (est.) (Jan 2021) | 55 | (+4%) |
| Cybersecurity rating | A | More |
Key People/Management at Scipher Medicine
Alif Saleh
CEO
Slava Akmaev
Chief Technology Officer
Jerry Conway
Senior Vice President of Market Access
Brian McEvilly
Vice President of Sales and Marketing
Alison Stowell
Chief People Officer
Jeff Sachs
Chief Legal Officer
Scipher Medicine Office Locations
Scipher Medicine has an office in Waltham
Waltham, MA, US (HQ)
303 Wyman St
Scipher Medicine Financials and Metrics
Summary Metrics
Founding Date | 2014 |
Scipher Medicine total Funding | $35 m |
Scipher Medicine latest funding size | $25 m |
Time since last funding | a year ago |
Scipher Medicine investors | Khosla Ventures, Green D Ventures, Optum Ventures, Alumni Ventures Group, Total Access Fund, Northpond Ventures, Granpool, AVG Women's Fund |
Scipher Medicine's latest funding round in February 2020 was reported to be $25 m. In total, Scipher Medicine has raised $35 m
Scipher Medicine Cybersecurity Score
Scipher Medicine Online and Social Media Presence
317 Twitter followers
Scipher Medicine has 317 Twitter Followers. The number of followers has decreased 0.2% month over month and decreased 0.3% quarter over quarter
Scipher Medicine's Trends
Twitter Engagement Stats for @Scipherr
3.4k
Tweets
365
Following
317
Followers
1
Tweets last 30 days
23
Avg. likes per Tweet
100%
Tweets with engagement
Scipher Medicine Blogs
December 07, 2020
New Study Demonstrates Clinical Utility of PrismRA Test in Guiding Therapy Selection for Rheumatoid Arthritis Patients
Nine out of 10 responding rheumatologists stated the test would increase their confidence when making prescribing decisions WALTHAM, Mass. – DECEMBER 7, 2020Scipher Medicine, a precision immunology company matching patients with the most effective therapy, today announced findings from a clinical ut…
October 08, 2020
18th U.S. Surgeon General Joins Scipher Medicine
Dr. Regina Benjamin to Advise on Access to Precision Medicine Driving Better Health Outcomes for Patients with Autoimmune Diseases OCTOBER 8, 2020- WALTHAM, MAScipher Medicine, a precision immunology company matching patients with most effective therapy, has appointed former United States Surgeon Ge…
September 17, 2020
Scipher Medicine and Ambry Genetics Partner to Bring Precision Medicine Test for Rheumatoid Arthritis to Market
PrismRA® first-of-its-kind molecular signature test validated in Ambry’s central laboratory.Partnership provides infrastructure for rapid scaling and patient accessibility. SEPTEMBER 17, 2020- WALTHAM, MA, and ALISO VIEJO, CA – Scipher Medicine, a precision immunology company matching patients with …
August 27, 2020
New Strategy for Avoiding Waste and Improving Response for Highest Cost Therapies in Rheumatoid Arthritis
AMCP Science & Innovation Theater Webinar Drug costs for targeted autoimmune diseases account for a large and growing proportion of pharmacy spend per patient. Despite most rheumatoid arthritis patients receiving anti-TNF therapies as their first targeted treatment, 2 in 3 patients have an inade…
July 28, 2020
Scipher Medicine™ Announces Publication of Clinical Study Validating PrismRA®, a Blood Test Predicting Non-Response to TNF Inhibitor Therapies in Patients with Rheumatoid Arthritis
PrismRA identifies patients 6.6 times less likely to respond to TNFi therapy JULY 28, 2020- WALTHAM, MA- (Business Wire)- Scipher Medicine, a precision immunology company that helps match patients with their most effective therapy, today announced successful results from the PrismRA clinical validat…
July 22, 2020
Clinical Validation of a Blood-Based Predictive Test for Stratification of Response to Tumor Necrosis Factor Inhibitor Therapies in Rheumatoid Arthritis Patients
Abstract: Objectives: For rheumatoid arthritis (RA) patients failing to achieve treatment targets with conventional synthetic disease-modifying antirheumatic drugs, tumor necrosis factor (TNF)-α inhibitors (anti-TNF therapies) are the primary first-line biologic therapy. In a cross-cohort, cross-pla…
Scipher Medicine Frequently Asked Questions
When was Scipher Medicine founded?
Scipher Medicine was founded in 2014.
Who are Scipher Medicine key executives?
Scipher Medicine's key executives are Alif Saleh, Slava Akmaev and Jerry Conway.
How many employees does Scipher Medicine have?
Scipher Medicine has 55 employees.
Who are Scipher Medicine competitors?
Competitors of Scipher Medicine include Ixico, Savonix and Medefer.
Where is Scipher Medicine headquarters?
Scipher Medicine headquarters is located at 303 Wyman St, Waltham.
Where are Scipher Medicine offices?
Scipher Medicine has an office in Waltham.
How many offices does Scipher Medicine have?
Scipher Medicine has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies